Clinical Trial Update: SWitching to Abilify Trial (SWAT) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting the completion of the SWAT trial evaluating switching to Abilify (aripiprazole) for schizophrenia. Sponsor listed as Kor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED